Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOI)

2.8800
+0.1700
+(6.27%)
At close: 4:00:01 PM EDT
2.8700
-0.01
(-0.35%)
After hours: 7:37:29 PM EDT
Loading Chart for TOI
  • Previous Close 2.7100
  • Open 2.8900
  • Bid 2.8400 x 1000
  • Ask 2.9700 x 100
  • Day's Range 2.6320 - 2.9450
  • 52 Week Range 0.1250 - 2.9600
  • Volume 1,225,625
  • Avg. Volume 850,281
  • Market Cap (intraday) 252.748M
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7500
  • Earnings Date May 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

theoncologyinstitute.com

825

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TOI

View More

Performance Overview: TOI

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TOI
832.04%
S&P 500 (^GSPC)
8.60%

1-Year Return

TOI
144.07%
S&P 500 (^GSPC)
6.02%

3-Year Return

TOI
62.35%
S&P 500 (^GSPC)
25.85%

5-Year Return

TOI
70.31%
S&P 500 (^GSPC)
92.15%

Compare To: TOI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TOI

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    237.83M

  • Enterprise Value

    311.31M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    66.27

  • Enterprise Value/Revenue

    0.79

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.44%

  • Return on Assets (ttm)

    -19.67%

  • Return on Equity (ttm)

    -213.36%

  • Revenue (ttm)

    393.41M

  • Net Income Avi to Common (ttm)

    -53.01M

  • Diluted EPS (ttm)

    -0.7500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.67M

  • Total Debt/Equity (mrq)

    3,434.19%

  • Levered Free Cash Flow (ttm)

    -7.46M

Research Analysis: TOI

View More

Company Insights: TOI

Research Reports: TOI

View More

People Also Watch